Journal of Health and Medical Sciences
Published: 17 December 2022
Anaesthetic Management of Patient with Left Atrial Myxoma, Coronary Artery Disease 3 Vessels Disease, and Parkinson’s Disease
Hana Nur Ramila, Adwitya Darmesta Gandhi N, Reza Widianto Sudjud
University of Padjadjaran, Hasan Sadikin General Hospital Bandung, Indonesia
Download Full-Text Pdf
Keywords: Anesthetic Management, CAD 3VD, Cardiopulmonary Bypass, Myxoma, Parkinson’s Disease
Myxomas are the most common primary benign intracavitatory tumour with the incidence of 0.5 per million populations. Myxomas account for 0.3% of all cardiac surgeries performed. Clinically, they are characterized by a triad of embolisation, obstruction of blood flow, and constitutional symptoms (Goodwin’s triad). Meanwhile Parkinson's disease is a degenerative neurologic disorder caused by degeneration of nerve cells in the substantia nigra causing weakness motor coordination. Symptoms include tremor, bradykinesia, rigidity, and postural instability. Achieving a satisfactory hemodynamic performance is the primary objective in the management of cardiac surgery patient. Optimal cardiac function ensures adequate perfusion and oxygenation of other organ systems (in particular vital organs) and improves the chances for an uneventful recovery from surgery. A 61-year old female diagnosed with Coronary Artery Disease 3 Vessel Disease (CAD 3 VD), Parkinson’s disease, and left atrial myxoma was brought to the emergency department with dyspnea. The patient has undergone angiography and the echocardiography result was LVEF 59% with global normokinetic, LA myxoma causing non-significant mitral flow. LA myxoma excision under general anaesthesia on CPB was planned. Balanced general anaesthesia on cardiopulmonary bypass forms the basis of Anaesthetic management of Cardiac myxomas. However specific individual considerations will have to be made regarding drugs, doses, regional anaesthetic choices, anticoagulation and post-operative management. There is no simple anesthetic technique for patients with Parkinson’. Therefore, careful preoperative assessment, administration of drugs during and after anesthesia, as well as avoiding agents that are known to trigger Parkinson's symptoms is a major factor in reducing postoperative morbidity and mortality.
MacGowan, S. W., Sidhu, P., Aherne, T., Luke, D., Wood, A. E., Neligan, M. C., & McGovern, E. (1993). Atrial myxoma: national incidence, diagnosis and surgical management. _Irish journal of medical science, 162(6),_223–226. https://doi.org/10.1007/BF02945200.
Castells, E., Ferran, V., Octavio de Toledo, M. C., Calbet, J. M., Benito, M., Fontanillas, C., Granados, J., Obi, C. L., & Saura, E. (1993). Cardiac myxomas: surgical treatment, long-term results and recurrence. _The Journal of cardiovascular surgery, 34(1),_49–53. https://pubmed.ncbi.nlm.nih.gov/8482704/
Goodwin J. F. (1963). Diagnosis of left atrial myxoma. _Lancet (London, England), 1(7279), 464–468. https://doi.org/10.1016/s0140-6736(63)92359-6.
Fang, B. R., Chiang, C. W., Hung, J. S., Lee, Y. S., & Chang, C. S. (1990). Cardiac myxoma—clinical experience in 24 patients. _International journal of cardiology, 29(3), 335–341. https://doi.org/10.1016/0167-5273(90)90123-m.
Namboodiri, K. K., Chaliha, M. S., Manoj, R. K., & Grover, A. (2004). Central nervous embolism as an usual presentation of left atrial myxoma. _Journal of postgraduate medicine, 50(2),151. http://www.bioline.org.br/pdf?jp04047
Swenson, J. D., Balley, P. L. (2005). Intraoperataive diagnosis of atrial myxoma by TEE._Miller’s Anaesthesia. Churcill Livingstone.
Disesa, V. J., Collins, J. J., Jr, & Cohn, L. H. (1988). Considerations in the surgical management of left atrial myxoma. _Journal of cardiac surgery, 3(1),_15–22. https://doi.org/10.1111/j.1540-8191.1988.tb00213.x.
Peters, M. N., Hall, R. J., Cooley, D. A., Leachman, R. D., & Garcia, E. (1974). The clinical syndrome of atrial myxoma. _JAMA, 230(5),_695–701. https://pubmed.ncbi.nlm.nih.gov/4479298/
Moritz, H. A., & Azad, S. S. (1989). Right atrial myxoma: case report and anaesthetic considerations. _Canadian journal of anaesthesia = Journal canadien d'anesthesie, 36(2), 212–214. https://doi.org/10.1007/BF03011447.
Bateman, T. M., Gray, R. J., Raymond, M. J., Chaux, A., Czer, L. S., & Matloff, J. M. (1983). Arrhythmias and conduction disturbances following cardiac operation for the removal of left atrial myxomas. _The Journal of thoracic and cardiovascular surgery, 86(4),_601–607. https://pubmed.ncbi.nlm.nih.gov/6621088/
Knepper, L. E., Biller, J., Adams, H. P., Jr, & Bruno, A. (1988). Neurologic manifestations of atrial
myxoma. A 12-year experience and review. _Stroke, 19(11),_ 1435–1440.
Ha, J. W., Kang, W. C., Chung, N., Chang, B. C., Rim, S. J., Kwon, J. W., Jang, Y., Shim, W. H., Cho, S. Y., Kim, S. S., & Cho, S. H. (1999). Echocardiographic and morphologic characteristics of left atrial myxoma and their relation to systemic embolism. _The American journal of cardiology, 83(11),_1579–A8. https://doi.org/10.1016/s0002-9149(99)00156-3.
Kumar, T.K.S., Ali, M., & Hirakannawar, A. (2004). Clinical experience and surgical considerations in the management of cardiac myxomas. _Indian Journal Thoracic Cardiovascular Surgery, 20,_ 77–82. https://doi.org/10.1007/s12055-004-0046-3
Morgan, G.E., Mikhail, M.S., & Murray M.J. (2006). _Anesthesia for patients with neurologic & psychiatric disease in Clinical anesthesiology._ Lange Medical Book/McGraw-Hill Medical Publishing Division.
Nicholson, G., Pereira, A. C., & Hall, G. M.